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SUMMARY
The transcriptional regulator CITED2 is essential for heart development. Here, we investigated the role of CITED2 in the specification of
cardiac cell fate frommouse embryonic stem cells (ESC). The overexpression of CITED2 in undifferentiated ESCwas sufficient to promote
cardiac cell emergence upon differentiation. Conversely, the depletion ofCited2 at the onset of differentiation resulted in a decline of ESC
ability to generate cardiac cells. Moreover, loss of Cited2 expression impairs the expression of early mesoderm markers and cardiogenic
transcription factors (Isl1, Gata4, Tbx5). The cardiogenic defects in Cited2-depleted cells were rescued by treatment with recombinant
CITED2protein.We showed thatCited2 expression is enriched in cardiac progenitors either derived fromESCormouse embryonic hearts.
Finally, we demonstrated that CITED2 and ISL1 proteins interact physically and cooperate to promote ESC differentiation toward cardio-
myocytes. Collectively, our results show that Cited2 plays a pivotal role in cardiac commitment of ESC.
INTRODUCTION
Cardiac morphogenesis results from the specification, dif-
ferentiation, and migration of spatially and temporally
distinct sets of cardiac precursor cells that give rise to the
mature cardiac tissue. The first multipotent cardiogenic
cells originate from the mesoderm formed at early stages
of gastrulation when cells of the epiblast ingress to
the primitive streak (Costello et al., 2011; David et al.,
2011; Garry and Olson, 2006; Kitajima et al., 2000; Tam
et al., 1997). The mesoderm first expresses the markers
BRACHYURY and FLK1 and subsequently the cardiogenic
marker MESP1 (Bondue et al., 2008; Chan et al., 2013; Ish-
itobi et al., 2011; Saga et al., 1999). The first (FHF) and sec-
ond (SHF) heart fields then arise from the cardiogenic
mesoderm to ultimately generate the atria, ventricles, and
outflow tract of the nascent heart (Cai et al., 2003; Domian
et al., 2009;Moretti et al., 2006). Both FHF and SHF progen-
itors express the transcription factors NKX2.5, TBX5,
GATA4, MEF2C, and ISL1, although TBX5 is predomi-
nantly present in cells of the FHF, and Isl1 expression is a
hallmark of SHF progenitors (Laugwitz et al., 2005; Moretti
et al., 2006; Vincent et al., 2010). In mouse, the tran-
scriptional modulator CITED2 is required for normal
embryogenesis. Deletion of Cited2 in the epiblast results
in embryonic lethality associated with multiple cardiovas-
cular defects (Bamforth et al., 2001, 2004; MacDonald
et al., 2008, 2013; Weninger et al., 2005; Yin et al.,
2002). Of important note, however, although Cited2 is
expressed in the early mesoderm (Dunwoodie et al.,
1998), conditional deletion of Cited2 in BRACHYURY-ex-
pressing mesoderm cells or MESP1-expressing cardiogenic
mesoderm progenitors did not significantly affect cardiac
development (MacDonald et al., 2008). In humans, muta-
tions in the gene encoding CITED2 are associated with
congenital heart disease (Chen et al., 2012; Sperling et al.,
2005).
The specification and differentiation of cardiac progen-
itor cells (CPC) and mature cardiovascular cells during the
in vitro differentiation of pluripotent stem cells recapitu-
late the cellular and molecular processes of embryonic
development (Blin et al., 2010; Bondue et al., 2008,
2011; Christoforou et al., 2008; Gai et al., 2009; Kattman
et al., 2011; Kouskoff et al., 2005; Laugwitz et al., 2005;
Moretti et al., 2006; Van Vliet et al., 2012; Yang et al.,
2008). In mouse, an acute Cited2 depletion reduces
the self-renewal capacity of most embryonic stem cells
(ESC), but a small population of Cited2-null ESC with
apparent characteristics of undifferentiated cells adapt to
the loss of Cited2 (Kranc et al., 2015; Li et al., 2012). Inter-
estingly, Cited2-null ESC showed an impairment of differ-
entiation, including cardiac commitment (Li et al., 2012).
To better understand the role of Cited2 at early stages
of mouse ESC differentiation, we here employ Cited2
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loss- and gain-of-function approaches to examine the role
of Cited2 during cardiac differentiation. Cited2 depletion
at the onset of differentiation significantly impairs the
expression of Brachyury, Mesp1, Isl1, Gata4, and Tbx5.
Conversely, CITED2 overexpression stimulates the expres-
sion of these genes in undifferentiated ESC and pro-
motes cardiac lineage commitment and differentiation.
We further show that Cited2 expression is highly associ-
ated with CPC populations, particularly cardiac progeni-
tors of the SHF. Finally, we show that CITED2 is recruited
to the promoter of the Isl1 gene, and provide evidence
that the human CITED2 and ISL1 proteins physically
interact and synergize to promote cardiogenesis from
ESC. Collectively our results show that Cited2 is a key
regulator of early cardiac lineage commitment and differ-
entiation of ESC.
RESULTS
CITED2 Overexpression Promotes ESC Differentiation
to Cardiac Lineages
The knockout of Cited2 in mouse ESC has been previously
reported to impair cardiomyocyte differentiation (Li
et al., 2012). To investigate whether the overexpression of
CITED2 promotes ESC differentiation into cardiac lineages,
we transfected undifferentiated mouse E14/T ESC with
an episomal plasmid expressing a FLAG-tagged human
CITED2 (flag-CITED2) or a control vector as previously
described (Kranc et al., 2015). Upon differentiation, high
levels of flag-CITED2 expression were detected in E14/T
ESC (named E14T/flagCITED2 hereafter) at the onset of
differentiation (day 0 [D0]) in comparison with the
endogenous Cited2 expression in control cells (named
E14T/Control hereafter). However, the ectopic expression
of flag-CITED2 in cells derived from E14T/flagCITED2
ESC rapidly declined during the first 3 days of differentia-
tion, and returned to control levels by D6 (Figure 1A). An
increase in the number of spontaneous contractile clusters
(beating foci), marking the occurrence of terminal cardio-
myocyte differentiation, was observed in cell cultures
derived from E14T/flagCITED2 ESC in comparison with
control cells (Figure 1B). Thus, the overexpression of flag-
CITED2 significantly promoted cardiomyocyte differentia-
tion, as confirmed by the elevated expression of cardiac
structural genes, such as a-cardiac myosin heavy chain
(Myh6) and cardiac troponin T (cTnT) transcripts detected
in these cells in comparison with control cells (Figure 1C).
The vascular endothelial growth factor receptor 2 (VegfR2, a
marker of endothelial differentiation) expression was also
increased in cells derived from E14T/flagCITED2 ESC,
while the expression of the skeletal troponin I (sTnI, amarker
of skeletal muscle differentiation) was unaffected by the
overexpression of flag-CITED2 (Figure S1A), suggesting
that flag-CITED2 overexpression supports ESC specifi-
cation to cardiovascular cell lineages. To unravel the
mechanism by which flag-CITED2 promoted the cardiac
differentiation process, we assessed the expression of tran-
scription factors known to play critical roles in the specifi-
cation of ESC to cardiac lineages, particularly Isl1, Gata4,
Nkx2.5, and Tbx5. Surprisingly, the overexpression of
flag-CITED2 significantly increased the transcript levels of
these factors in undifferentiated ESC (D0), and of Isl1 and
Gata4 at D6 of differentiation (Figure 1D). The increase in
the expression of Isl1 and Gata4 proteins was also detected
in undifferentiated E14/T ESC overexpressing flag-CITED2
(Figure S1B). Since CITED2 is a transcriptional modulator,
we hypothesized that flag-CITED2 enhanced Isl1, Gata4,
Nkx2.5, andTbx5 expression by a direct effect on their tran-
scriptional regulatory regions. Therefore, we investigated
by chromatin immunoprecipitation (ChIP) assays whether
flag-CITED2was recruited at the promoters of these factors.
A significant enrichment of the Isl1 promoter region was
detected in E14T/flagCITED2 ESC extracts immunoprecip-
itated with an anti-flag antibody in comparison with E14T/
Control extracts (Figure 1E). No difference of enrichment
was observed for the exon 1 of Isl1, or for the Nkx2.5,
Gata4, and Tbx5 promoter fragments tested in the same
conditions (Figure 1E). Interestingly, flag-CITED2 overex-
pression also significantly enhanced the occupancy of
Isl1 promoter and exon 1 by histones H3 trimethylated
on lysine 4 (H3triMeK4), a mark of actively transcribed
chromatin (Figure 1F). No enrichment of H3triMeK4
occupancy was detected at the promoters of Nkx2.5,
Gata4, and Tbx5 in the same extracts. Although these ex-
periments do not enable us to rule out the presence
of flag-CITED2 at other regulatory elements of Nkx2.5,
Gata4, and Tbx5 genes, they exposed its presence at the
Isl1 promoter. Moreover, the presence of flag-CITED2 at
Isl1 regulatory regionswas also correlatedwith an increased
recruitment of H3triMeK4 at these regions, suggesting that
flag-CITED2 may exert a direct positive effect on the
expression of Isl1.
Depletion of Cited2 in ESC Differentiation Affects
Cardiac Commitment
To further investigate the role of Cited2 in cardiac dif-
ferentiation, we used C2fl/fl[Cre] ESC, which allow the
conditional knockout of Cited2 by supplementation of
4-hydroxytamoxifen (4HT) to the culture medium (Kranc
et al., 2015). First, we analyzed Cited2 expression kinetics
by qPCR during the differentiation of control C2fl/fl[Cre]
ESC (Figures 2A and 2B, black bars). The pattern of Cited2
expression was biphasic, with a decrease of the transcript
levels from D0 to D2 of differentiation, followed by
an elevation from D3 onward (Figure 2B, black bars).
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A similar expression pattern for Cited2was also observed in
E14T/Control cells (Figure 1A, black bars). Next, we exam-
ined Cited2 expression in cells derived from C2fl/fl[Cre] ESC
treated with 4HT at D0 of differentiation during 48 hr, and
compared it with control cells derived from C2fl/fl[Cre] ESC
treatedwith ethanol used as vehicle (Figures 2A–2C).Cited2
depletion was incomplete during the time course of differ-
entiation since Cited2 transcripts remained detectable at
D5 and D12 of differentiation in cells treated with 4HT,
although these levels were significantly reduced in compar-
ison with control cells (Figure 2B). Noticeably, the number
of beating foci was reduced in cell cultures derived from
ESC depleted of Cited2 at D0 compared with control cells
(Figure 2D). The decline of Myh6 and cTnT transcripts
expression and the reduced number of cells expressing
cTNT protein in cultures treated with 4HT supported the
requirement of Cited2 expression for ESC differentiation
into cardiac lineages (Figures 2E and 2F). To evaluate the
expression and organization of sarcomeric proteins in car-
diomyocytes, we performed fluorescent immunodetection
of the a-ACTININ and MYOSIN HEAVY CHAIN (MF20)
proteins in cells at D10 of differentiation derived from
C2fl/fl[Cre] ESC treated either with ethanol or 4HT at D0
(Figure 2G). Approximately 25%–30% of the cells derived
from control C2fl/fl[Cre] ESC were positively stained for
a-ACTININ or MF20 and presented some degree of organi-
zation of the sarcomeric apparatus (Figures 2G and S1C).
The depletion of Cited2 by treatment of C2fl/fl[Cre] ESC
with 4HT resulted in the decline of a-ACTININ and MF20
protein detection, and in the diminution of the number
of cells stained for a-ACTININ or MF20 in comparison
with the control cells (Figures 2G and S1C). Together, these
Figure 1. Ectopic Expression of Human
CITED2 Promotes Cardiac Differentiation
(A) Relative expression of flag-Cited2 during
differentiation, determined by qPCR in
E14/T ESC transfected with a plasmid ex-
pressing FLAG-tagged CITED2 (flag-CITED2)
or the control empty plasmid (vector). NS,
not significant.
(B) Number of colonies with beating foci
counted at the indicated days of differenti-
ation in cells treated as described in (A).
(C) Expression levels of Myh6 and cTnT
determined by qPCR at D6 and D12 of dif-
ferentiation in cells treated as described
in (A).
(D) Expression of Isl1, Gata4, Nkx2.5, and
Tbx5 at D0, D3, D6, and D12 of differentia-
tion in E14/T-derived cell extracts prepared
as described in (A).
(E) Top: diagram of the mouse Isl1 genomic
contig showing the transcriptional start site
(arrow), exon 1 (gray box), and positions of
PCR primers (arrow heads) used in ChIP as-
says. Bottom: enrichment of Isl1 promoter
(Isl1-A) and exon 1 (Isl1-B), and Nkx2.5,
Gata4, and Tbx5 promoters in extracts of
undifferentiated E14/T ESC overexpressing
flag-CITED2 or control cells by ChIP assays
with anti-FLAG monoclonal antibody.
(F) Enrichment of the genomic regions of
Isl1, Nkx2.5, Gata4, and Tbx5 in ChIP assays
with extracts and primers described in (E),
using an anti-histone H3triMeK4-specific
antibody.
Results are presented as the mean ± SEM of
three independent biological experiments.
Stem Cell Reports j Vol. 7 j 1037–1049 j December 13, 2016 1039
observations were consistent with the requirement of
Cited2 for ESC-derived cardiogenesis. In contrast, Cited2
depletion did not significantly alter the expression of
Nestin and bIII-Tubulin (markers of neural cells, ectoderm
origin) and the a-fetoprotein (hepatic marker, endoderm
origin). Cited2 depletion did result in a reduction of Foxa2
(endoderm and hepatocyte marker) expression at D12 (Fig-
ure 2F), consistent with the role played by Cited2 in liver
development (Qu et al., 2007). Interestingly, the treatment
of C2fl/fl[Cre] ESC with 4HT at D2 of differentiation only
mildly affected the emergence of beating clusters, while
no alteration was observed after 4HT treatment at D4 or
D6 of differentiation in comparison with control cells (Fig-
ure 2D). These observations suggest that Cited2 supports
ESC specification to cardiomyocyte lineages during the first
2–3 days of differentiation. In agreement with these results,
we showed that Cited2-null C2D/D[LA11] ESC devoid of
Cited2 expression (Kranc et al., 2015) have a reduced capac-
ity to generate cardiac contractile clusters when compared
to control C2fl/fl ESC (Figure 3A). To confirm that the car-
diac differentiation defects observed in Cited2-depleted
cells were due to the loss of Cited2 expression, C2fl/fl[Cre]
ESC treated with 4HTat D0 were transduced with a human
recombinant CITED2 protein (sharing interchangeable
functions with the mouse protein in cardiac development
[Chen et al., 2012; Kranc et al., 2015]) fused at its N-termi-
nal domain with a stretch of eight arginines (termed
8R-CITED2). Polyarginine peptides are transduction do-
mains that enable proteins to cross the cellular membrane
when applied to the culture medium (Lundberg et al.,
2003). The purified 8R-CITED2 added into the culture
medium crossed the cellular membrane, translocated into
the nucleus of Cited2-null ESC, and interfered with the
high-affinity binding of overexpressed human CITED2
Figure 2. Cited2 Is Important for Early
Steps of Cardiac Differentiation
(A) Timeline depicting the protocol used for
differentiation of mouse ESC from D0 on-
ward. The time of ethanol or 4HT treatment
and the days of beating activity assessment
are indicated.
(B) Expression of Cited2 determined by qPCR
at D0, D2, D3, D5, and D12 of differentiation
in cells derived from C2fl/fl[Cre] ESC treated
at D0 with 4HT or ethanol for 48 hr.
(C) CITED2 protein levels determined by
western blotting in extracts from C2fl/fl[Cre]
ESC, 48 hr after incubation with ethanol or
4HT. Loading in each lane was monitored by
detection of b-TUBULIN.
(D) Percentage of colonies with beating foci
derived from C2fl/fl[Cre] ESC treated with
ethanol or 4HT at D0, D2, D4, and D6 of
differentiation.
(E) Quantification by flow cytometry of cells
expressing cTNT at D12, treated as described
in (B). The percentage of cells expressing
cTNT over the total number of cells is
indicated.
(F) Expression levels determined by qPCR
of Myh6, cTnT, Foxa2, a-fetoprotein (Afp),
Nestin, and bIII-tubulin (bIII-tub.) at
D12 of differentiation in cells treated as
described in (B).
(G) Immunofluorescent detection of
a-ACTININ (left panels, red staining) and
MYOSIN HEAVY CHAIN MF20 (right panels,
red staining) in C2fl/fl[Cre] ESC-derived cells
at D10 of differentiation, after treatment
for 2 days with ethanol (upper panels) or 4HT (lower panels) at D0. Nuclei were counterstained using DAPI (blue), and cells were examined
on at 1003 magnification.
Results in (B), (D), (E), and (F) are presented as the mean ± SEM of three independent biological experiments.
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protein to the CH1 domain of p300 (Freedman et al.,
2003), suggesting that 8R-CITED2 is functional (Fig-
ure S2). Interestingly, the supplementation of 8R-CITED2
at D2 of differentiation in the culture medium of
C2fl/fl[Cre] ESC treated with 4HT at D0 restored the emer-
gence of beating foci to control levels (Figure 3B). These
results argue that the cardiogenic defects of Cited2-
depleted ESC are caused by the loss of Cited2 expression.
Altogether, these observations suggested that Cited2 is
important for early events of ESC commitment to cardiac
cell lineages.
Cited2 Is Necessary for the Expression of Genes
SpecifyingCardiacMesodermandCardiac Progenitors
During early differentiation, the expression of pluripo-
tency markers Oct4, Sox2, and Nanog was silenced with
comparable rates in control and 4HT-treated cells (Fig-
ure S1D). Thus, a misregulation of pluripotency factors
cannot account for the deficiency in cardiac differentiation
of Cited2-depleted ESC. Next, we assessed the expression of
genes marking early (cardiac) mesoderm induction such as
Activin A,Nodal, Brachyury, andMesp1 (Figures 3C and 3D).
No significant alteration in Nodal and Activin A expression
Figure 3. Loss of Cited2 Impairs
Expression of Genes Specifying Cardiac
Mesoderm
(A) Percentage of colonies with beating foci
derived from C2fl/fl and C2D/D[LA11] ESC at
D8 and D10 of differentiation.
(B) Percentage of colonies with beating foci
counted at 8 and 10 days after the initiation
of differentiation in cell cultures derived
from C2fl/fl[Cre] ESC treated with ethanol or
4HT at D0 of differentiation, and with 4HT
at D0 of differentiation and supplemented
with recombinant 8R-CITED2 protein at D2
of differentiation (4HT + 8R-CITED2).
(C) Expression of Activin A and Nodal
determined by qPCR at D2 and D3 of dif-
ferentiation in cultures derived from
C2fl/fl[Cre] ESC treated with 4HT or ethanol
at D0 for 48 hr.
(D) Expression of mesoderm markers (Bra-
chyury and Mesp1) at D2, D3, D5, and D12
of differentiation in cells generated from
C2fl/fl[Cre] ESC treated as described in
(Figure 2B).
(E) Expression of Isl1, Gata4, Nkx2.5, and
Tbx5 in cell cultures as described in (D).
The inserts for Isl1 and Tbx5 detail the
expression of these genes at D5 and D3,
respectively.
(F) Relative expression of Brachyury, Mesp1,
Isl1, Gata4, Nkx2.5, and Tbx5 determined
by qPCR at D5 of differentiation in cul-
tures derived from untreated C2fl/fl and
C2D/D[LA11] ESC, and C2D/D[LA11] ESC
supplemented with the recombinant 8R-
CITED2 protein (C2D/D[LA11] + 8R-CITED2)
at D2 of differentiation for 48 hr. Gene
expression in C2fl/fl ESC was set to 1.
(G) Enrichment of Isl1 genomic regions
in extracts of E14/T ESC-derived cells at
D5 by ChIP assayswith anti-CITED2 or control
(immunoglobulin G) polyclonal antibodies.
Results are presented as the mean ± SEM of
three independent biological experiments.
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was observed at D2 and D3 in control and D0 Cited2-
depleted cell cultures (Figure 3C). In contrast, Brachyury
expression was significantly reduced at D3 but restored at
D5, and Mesp1 expression was markedly downregulated
at D3 and D5 (Figure 3D). The decrease of Brachyury and
Mesp1 expression is in agreement with a previous report
that had indicated thatCited2 supportsmesoderm differen-
tiation (Li et al., 2012) and with our observations suggest-
ing that CITED2 is important during the first 2–3 days of
ESC differentiation (Figure 2). In addition, the expression
of Isl1, Gata4, and Tbx5 transcripts, as well as the expres-
sion of Isl1 and Gata4 proteins, was reduced at D5 of differ-
entiation in Cited2-depleted cells (Figures 3E and S1B). Isl1
expression levels were also lower at D2 while Tbx5 expres-
sion remained decreased at D12 (Figure 3E). The expression
ofNkx2.5was unchanged in similar conditions (Figure 3E).
Since the treatment of C2fl/fl[Cre] ESC with 4HT at D0
only achieved a partial knockout of Cited2 (Figure 2B),
the remaining Cited2 expression may confound the effects
ofCited2 depletion on gene expression. Therefore, to clarify
the consequences of Cited2 loss on Brachyury, Mesp1, Isl1,
Gata4,Nkx2.5, and Tbx5 expression, we differentiated con-
trol C2fl/fl ESC and Cited2-null C2D/D[LA11] ESC, which are
impaired for cardiac differentiation (Figure 3B). In this
context Gata4 expression was not altered, but a significant
downregulation of Brachyury, Mesp1, Isl1, Nkx2.5, and
Tbx5 expression was detected in cultures derived from
C2D/D[LA11] ESC at D5 of differentiation in comparison
with control cells (Figure 3F). Interestingly, supplementa-
tion of C2D/D[LA11] ESC-derived cells at D2 of differentia-
tion with 8R-CITED2, stimulated Brachyury, Mesp1, Isl1,
Nkx2.5, and Tbx5 expression at D5 of differentiation with
Isl1 expression being restored to control levels (Figure 3F).
This observation further argues for a mechanistic link
between Cited2 and Isl1 expression levels. To determine
whether endogenous CITED2 is recruited to the promoter
of Isl1 at D5 of differentiation, we performed ChIP using
anti-CITED2 and control polyclonal antibodies with
cellular extracts prepared from cells derived from E14/T
ESC (Figure 3G). Endogenous CITED2 was specifically de-
tected at the promoter region of Isl1 in these cells at D5
of differentiation, suggesting that CITED2 binds to Isl1
promoter in cells derived from ESC. Together, these obser-
vations suggested that Cited2 not only supports mesoderm
induction but also regulates the expression of key genes
during CPC specification including Isl1.
Cited2 Is Expressed in Cardiac Progenitors
Since Cited2 expression was associated with the expression
of CPCmarkers, such as Isl1, Nkx2.5, Gata4, and Tbx5 (Fig-
ures 1D, 3E, and 3F), we sought to determine whether
Cited2 was expressed in CPC. For this purpose, we used
mouse AD2 ESC harboring the dsRed (R) and eGFP (G)
genes under the control of the Mef2c/AHF and Nkx2.5 car-
diac-specific enhancers, respectively (Domian et al., 2009).
The differentiation of AD2 ESC originates R+/G, R/G+,
R+/G+, and R/G cell populations equivalent to CPC of
the pharyngeal mesoderm, FHF CPC, committed ventricu-
lar CPC of the SHF, and non-cardiac cells, respectively (Do-
mian et al., 2009). Cited2 expression, assessed by qPCR in
AD2-derived cell populations isolated by fluorescence-acti-
vated cell sorting at D6 of differentiation, revealed that
Cited2 transcripts were enriched in all CPC populations
when compared with R/G cells, with higher levels of
expression observed in R+/G+ cells (Figures 4A and 4B).
The expression of Isl1, Nkx2.5, Gata4, and Tbx5 in the
distinct CPC populations (Figure S1E) was as previously re-
ported (Domian et al., 2009). To determine whether Cited2
promotes the emergence of CPC, 2 days prior to differenti-
ation we transiently transfected AD2 ESC with either a
control vector or the plasmid expressing flag-CITED2
(Figure 4C). The expression of flag-CITED2 stimulated
endogenous Isl1 expression at D0, as observed in E14/T
cells (Figure 1D), and significantly increased the number
of R+/G+ cells derived from AD2 ESC differentiation at D6
(Figure 4D). In addition, the expression profile of Cited2
in cardiac progenitors in vivo was assessed in CPC pop-
ulations isolated from embryonic day 9.5 (E9.5) hearts
of mouse transgenic embryos harboring the dsRed and
eGfp genes (Domian et al., 2009). Interestingly, Cited2
expressionwas enriched in the R+/G+ subpopulation simul-
taneously expressing Isl1 and Nkx2.5 (Figure 4E). Collec-
tively, these observations indicated that Cited2 is expressed
in FHF and SHF CPC derived from ESC.
CITED2 and ISL1 Proteins Interact and Synergize to
Enhance Cardiac Differentiation
ISL1 is a protein with two LIM domains located at its N-ter-
minal domain, both important for SHF expansion and
morphogenetic control of cardiogenesis (Witzel et al.,
2012). Since CITED2 binds to the LIM domain of the tran-
scription factor LHX2 (Glenn and Maurer, 1999), we
hypothesized that ISL1 and CITED2 proteins might
physically interact. We therefore synthesized a 35S-labeled
myc-tagged full-length human ISL1 protein (myc-ISL1)
by coupled in vitro transcription-translation, and tested
for its ability to bind to a glutathione S-transferase (GST)-
CITED2 fusion protein (Figure 5A). Myc-ISL1 interacted
specifically with GST-CITED2 full-length protein and the
C-terminal residues of CITED2 (amino acids 66–270). It
also interacted weakly with CITED2 N-terminal residues
(amino acids 2–214). To confirm the interaction between
CITED2 and ISL1 in cells, we used the anti-FLAG antibody
to immunoprecipitate protein extracts from HEK293T cells
expressing either myc-ISL1 alone or myc-ISL1 and flag-
CITED2. Immunopurified proteins were then analyzed by
1042 Stem Cell Reports j Vol. 7 j 1037–1049 j December 13, 2016
western blot with anti-ISL1 and anti-FLAG antibodies (Fig-
ure 5B). Myc-ISL1 was co-immunoprecipitated with flag-
CITED2, implying that ISL1 and CITED2 were in protein
complexes in HEK293T cells. We also visualized ISL1-
CITED2 interaction in living cells using vectors expressing
either ISL1 in fusion with the N-terminal domain of the
fluorescent protein VENUS (VEN-ISL1), CITED2 in fusion
with the C-terminal domain of VENUS (VEC-CITED2), or
control vectors to perform bifluorescence complementa-
tion (BiFC) assays (Machado-Oliveira et al., 2015). The co-
transfection of VEN-ISL1 and VEC-CITED2 in E14/T cells
resulted in a specific detection of fluorescence, confirming
that ISL1 and CITED2 associate in these cells (Figures 5C
and S3).
To test the functional significance of CITED2-ISL1 inter-
action, we co-transfected Hep3B cells with vectors express-
ing myc-ISL1 and flag-CITED2 together with a reporter
construct harboring luciferase under the control of a com-
posite regulatory region containing the Mef2c cardiac-
specific enhancer, which is a direct target of Isl1 (Witzel
et al., 2012). The transfection of myc-ISL1 vector increased
the reporter activity, and this was further enhanced by
co-transfection of flag-CITED2 vector (Figure 5D). These
observations provide evidence that myc-ISL1 and flag-
CITED2 synergize to stimulate the activity of an ISL1-
responsive reporter.
To determine whether CITED2 and ISL1 cooperate to
promote ESC differentiation toward cardiac cell fate, the
number of beating foci originating from undifferentiated
E14/T ESC expressing VEC-CITED2 and VEN-ISL1 individ-
ually or in combination was evaluated at D8, D10, and D12
of differentiation (Figure 5E). The transfection of VEC-
CITED2 or VEN-ISL1 individually led to the emergence of
beating foci at similar levels, while the co-transfection of
VEC-CITED2 and VEN-ISL1 significantly increased the
number of contractile foci at D12. Altogether, these obser-
vations provide evidence for a physical and functional
interaction between ISL1 and CITED2 that promotes ESC
differentiation toward cardiac cell lineages.
DISCUSSION
In this study, we show that Cited2 is required for early car-
diac commitment of mouse ESC, in agreement with a
previous study (Li et al., 2012). We and others have
Figure 4. CITED2 Is Expressed in Cardiac
Progenitors and its Overexpression Pro-
motes Cardiac Progenitor Specification
(A) Representative flow cytometry plots of
the R+/G, R/G+, R+/G+, and R/G cell
populations derived from AD2 ESC at D6 of
differentiation. Numbers indicate percent-
age of cells within each gate.
(B) Relative expression of Cited2 determined
by qPCR in cell populations derived from
AD2 at D7 differentiation. Expression of
the indicated genes is reported relative to
their expression in non-cardiac cells R/G
set at 1.
(C) Relative expression of ectopic CITED2
and endogenous Isl1 determined by qPCR
at D0 and D5 of differentiation, in AD2 ESC
transiently transfected with a plasmid ex-
pressing flag-CITED2 or a control vector.
flag-Cited2 and Isl1 expressions are relative
to their expression in cells transfected with
the control vector set at 1.
(D) Quantification, at D6 of differentiation
by flow cytometry, of R+/G, R/G+, R+/G+,
and R/G populations derived from AD2
ESC transfected with a plasmid expressing
flag-CITED2 or a control vector. Cell numbers are reported relative to background determined at the onset of differentiation, which was
set at 1.
(E) Relative expression of Cited2, Isl1, and Nkx2.5 determined by qPCR in embryonic cardiac progenitor populations at E9.5.
Results in (B) and (E) are presented as the mean ± SEM of three independent biological experiments, while results in (C) and (D) are
presented as the mean ± SEM of two independent biological experiments each performed in technical triplicates.
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Figure 5. CITED2 Binds to ISL1 and Both Synergize to Enhance Cardiac Differentiation
(A) Binding of 35S-labeled myc-ISL1 protein either to GST alone or GST fused to full-length CITED2 (GST-CITED2, amino acid residues
2–270), the N-terminal fragment GST-CITED2(2–214), or the C-terminal fragment GST-CITED2(66–270). Ten percent of labeled myc-ISL1
used for the binding assay was loaded as the input. Top panel: autoradiogram showing the binding of 35S-labeled ISL1 to GST and
GST-CITED2 proteins. Bottom panel: Coomassie blue stain of the gels showing relative amounts of GST and GST-CITED2 proteins.
(B) Whole-cell extracts from HEK293T cells expressing myc-ISL1 alone or in combination flag-CITED2 immunoprecipitated (IP) with an
anti-FLAG antibody, and proteins detected by western blot (WB) with anti-ISL1 and anti-FLAG antibodies. Five percent of the input was
also loaded.
(C) Interaction between CITED2 and ISL1 visualized by BiFC assays in undifferentiated E14/T ESC. Fluorescence emission (right panels) and
morphological aspect of E14/T cells as observed in bright field (left panels) was examined 1 day after transfection and in embryoid bodies
at D2 and D5 of differentiation.
(legend continued on next page)
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demonstrated that Cited2 expression promotes mouse ESC
self-renewal (Chen et al., 2012; Kranc et al., 2015; Pritsker
et al., 2006). Interestingly, we show that the deletion of
Cited2 in ESC or depletion ofCited2 at the onset of differen-
tiation impairs cardiac lineage commitment. Remarkably,
we determine that endogenous expression of Cited2 tran-
scripts is biphasic during ESC differentiation, starting
with a decrease from D0 to D2. This decline of Cited2
expression upon differentiation might be necessary for
ESC to switch from a non-permissive to a permissive
differentiation state. In a second phase, Cited2 expression
increases from D3 of differentiation onward, implying
that Cited2 might be required for subsequent differentia-
tion processes. This is corroborated by the rescue of
the cardiac differentiation defects in Cited2-depleted ESC
with the supplementation of the recombinant CITED2
protein to the cells at D2 of differentiation, a day before
the levels of endogenous Cited2 start to increase during
differentiation.
The impairment of cardiac differentiation resulting from
Cited2 depletion at the onset of ESC differentiation may
be due to a consequent downregulation of Brachyury and
Mesp1 expression. The decrease of Isl1, Nkx2.5, Gata4,
and Tbx5 expression that we observed in Cited2-depleted
cells at D5 of differentiation, which corresponds to the
time when CPC emerge, might be a consequence of
Mesp1 downregulation, since these genes are activated by
MESP1 to promote cardiogenesis and CPC specification
during cardiac development and ESC differentiation (Bon-
due et al., 2008; David et al., 2011). On the other hand,
we show that Cited2 expression is enriched in CPC, and
CITED2 protein is recruited to Isl1 promoter at D5 of differ-
entiation during CPC specification. This suggests that
CITED2may play a role in CPC specification, proliferation,
and/or differentiation. In agreement with this hypothesis,
flag-CITED2 overexpression promoted both the emergence
of CPC and terminal cardiomyocyte differentiation from
ESC, and increased Isl1, Nkx2.5, Gata4, and Tbx5 expres-
sion in undifferentiated ESC. Fluctuations in the expres-
sion of genes encoding transcription factors with capacities
to instruct lineage specification have been evidenced in un-
differentiated pluripotent ESC and, in accordance with the
transcripts expressed, subsets of ESC might be prone to
undergo particular differentiation programs (Lanner and
Rossant, 2010). The overexpression of CITED2 in undiffer-
entiated ESC might specify and promote CPC and cardiac
differentiation by raising the expression of the pro-cardio-
genic factors Isl1, Nkx2.5, Gata4, and Tbx5. Interestingly,
the transdifferentiation of human dermal fibroblasts into
cardiac progenitors by expression of MESP1 and ETS2 has
been shown to stimulate the expression of CITED2 (Islas
et al., 2012), suggesting that CITED2may play a role in car-
diac progenitor specification and/or functions. Therefore,
CITED2 overexpression might be instrumental for specifi-
cation of CPC and cardiomyocyte differentiation from
pluripotent stem cells.
We also provided evidence for a privileged regulatory
interaction between Cited2 and Isl1. Indeed, our ChIP as-
says show that CITED2 is specifically recruited at the Isl1
promoter. Furthermore, supplementation of Cited2-null
ESC with CITED2 recombinant protein restores the expres-
sion of Isl1 to normal levels at D5 of ESC differentiation.
In addition, ESC overexpressing flag-CITED2 are enriched
for H3triMeK4 at the Isl1 regulatory elements, which
marks transcriptionally active chromatin. Themechanisms
by which flag-CITED2 overexpression contribute to the
enrichment of H3triMeK4 at the Isl1 loci and increase
Gata4 and Nkx2.5 expression in undifferentiated ESC
remain to be elucidated. Interestingly, at the protein level
we demonstrated that ISL1 and CITED2 interact, delin-
eated the amino acids 66–214 of CITED2 as part of the
ISL1 interacting domain, and by transient transfection
assays established that CITED2 increased ISL1-mediated
Mef2c-enhancer activity and that ISL1 and CITED2 have a
synergistic effect on cardiac cells derived from ESC. The
exact molecular mechanism by which CITED2 and ISL1
cooperate in cardiac specification remains to be clarified,
but it has been recently demonstrated that in mouse
(D) Hep3B cells were transiently co-transfected with 40 ng of Mef2c-luc reporter, together with 100 ng of either myc-ISL1 expressing or
empty control vector, and increasing amounts of a flag-CITED2-expressing plasmid (0, 50, and 100 ng) combined with the empty plasmid
to achieve a total of 400 ng in each condition. The luciferase activity was normalized for the b-GALACTOSIDASE activity conferred by CMV-
lacZ (100 ng). Relative luminescence units (RLU) are presented relative to values of the Mef2c-luc transfected with the control vectors
set at 1.
(E) Percentage of colonies with beating foci at D8, D10, and D12 in cultures derived from differentiation of E14/T ESC transfected
individually or in combination with vectors expressing VEN-ISL1 and VEC-CITED2, or control vectors at D0.
(F) Model for the role of CITED2 during cardiogenesis of ESC, as supported by the data from our study. CITED2 is required for the normal
expression of mesoderm progenitor markers such as Brachyury andMesp1. In addition, at this stage CITED2 contributes to the expression of
Isl1, Nkx2.5, Gata4, and Tbx5, which are CPC markers. The overexpression of CITED2 triggers an increase of Isl1, Nkx2.5, Gata4, and Tbx5
expression in undifferentiated ESC, which may favor cardiac differentiation. Finally, CITED2 and ISL1 proteins physically interact and
cooperatively promote cardiac differentiation.
Results in (D) and (E) are presented as the mean ± SEM of three independent biological experiments.
Stem Cell Reports j Vol. 7 j 1037–1049 j December 13, 2016 1045
embryonic hearts and cardiac progenitors ISL1 interacts
with p300 to selectively promote H3 acetylation at the
Mef2c promoter (Yu et al., 2013). Since CITED2 interacts
strongly with p300, it would be of interest to determine
whether CITED2 cooperates with p300 to promote its func-
tional interaction with ISL1.
Altogether, our results indicated that Cited2 contributes
to the expression of a subset of pivotal cardiopoietic genes
involved in mesoderm and cardiac progenitor specifica-
tion (Figure 5F). During mouse embryonic development,
Cited2 expression was detected in the early mesoderm-
and cardiac-derived structures (Dunwoodie et al., 1998),
but rather surprisingly a Brachyury/T-Cre orMesp1-Cre con-
ditional Cited2 knockout only resulted in infrequent and
minor heart developmental defects of mouse embryos,
while Cited2 knockout in the epiblast consistently caused
heart malformations (Bamforth et al., 2001; MacDonald
et al., 2008). In the present report, we show that Cited2
depletion at the onset of differentiation causes the most
severe impact on cardiac differentiation, and results also
in the impairment of Brachyury and Mesp1 expression at
D3. Interestingly, the cardiogenic defects due to the loss
of Cited2 expression at D0 were reversed by supplementa-
tion of the 8R-CITED2 at D2 of differentiation. On the
other hand, Cited2 depletion at later time points (D2,
D4, and D6) had little or no effect on cardiogenesis.
Together, these observations indicate that Cited2 function
is important for early commitment of ESC to mesoderm
and/or cardiac specification, or at least contribute to the
correct expression of Brachyury and Mesp1, or other genes
crucial for these processes. Therefore, the lack of a strong
phenotype in Brachyury/T-Cre and Mesp1-CreCited2 condi-
tional knockout might be because the depletion of Cited2
in these embryos was triggered after Brachyury and Mesp1
were activated and after the requirement for Cited2. Of
particular interest, we show that CITED2 stimulates the
expression of Isl1, a marker of SHF cardiac progenitors,
and binds to its promoter at the time of CPC specification.
We also show that Cited2 expression is enriched in SHF
cardiac progenitors derived either from ESC or mouse
E9.5 embryonic hearts. Moreover, Cited2-null embryos
display a variety of cardiac developmental defects such
as ventricular septal defects with overriding aorta or dou-
ble-outlet right ventricle, outflow tract defects, and trans-
position of the great arteries, which may result from
anomalies of SHF and cardiac neural crest cell progenitors
known to express ISL1 (Bamforth et al., 2001; Bruneau,
2013). Therefore, CITED2 and ISL1 may also interact
during heart development and play a critical role for the
fulfillment of CPC functions in this process. It would
be of interest to investigate the contribution of the
CITED2-ISL1 interaction in CPC functions both in vitro
and in vivo.
EXPERIMENTAL PROCEDURES
All mice were cared for within the Animal Care facilities of
the Massachusetts General Hospital under the supervision
of an active and functioning Subcommittee on Research
Animal Care (SRAC), which serves as the Institutional An-
imal Care and Use Committee (IACUC) as required by
the Public Health Service (PHS) Policy on Humane Welfare
Regulations.
Embryonic Stem Cells, Culture Conditions, and
Isolation of Cardiac Progenitor Populations
Apple D2 (AD2), C2fl/fl, C2D/D[LA11], C2fl/fl[Cre], and E14/T
mouse ESC lines were described previously, and were cultured
on gelatin-coated plates in undifferentiating medium supple-
mented with LIF (Chambers et al., 2003; Domian et al., 2009;
Kranc et al., 2015). All ESC lines were differentiated using
the hanging-drop method in medium containing 20% fetal
bovine serum without LIF supplementation (differentiation
medium).
Flow Cytometry Analysis
For detection of cardiac troponin I type 3 (cTNT), cells were fixed
with 0.5% paraformaldehyde for 20 min at room temperature,
blocked, and permeabilized with PBS containing 0.5% BSA and
0.1% saponin for 5 min at 4C, washed with blocking solution,
and incubated for 1 hr at 4C with a monoclonal anti-mouse
cTNT antibody (NB110-2546, Novus Biologicals) at a 1:800
dilution followed by 1 hr of incubation at 4C with a secondary
goat anti-mouse immunoglobulin G conjugated with Alexa 488
(A21202, Life Technologies) used at 1:2,000 dilution. Flow cytom-
etry analyses were performed on a FACSCalibur (BD Biosciences)
operating at 488 nm excitation with standard emission filters.
Baseline of noise fluorescence was established with cells incubated
only with the secondary antibody.
Real-Time qPCR
Total RNA isolation, cDNA synthesis, and qPCR assays were car-
ried out as previously described (Kranc et al., 2015) with the
primers listed in Table S1. The primer set designated Cited2 detects
both mouse endogenous Cited2 and human exogenous flag-
CITED2. For the selection of reliable reference genes, the expres-
sion of three reference genes, hprt, Gapdh, and 18S was tested in
samples prepared from C2fl/fl[Cre] and E14/T ESC at different
time points of the differentiation (Figure S3E). Gapdh and 18S
showed a very consistent expression across the differentiation
process of both cell types. We opted for the normalization of
gene expression levels to Gapdh, as previously performed (Kranc
et al., 2015).
Immunochemistry
Immunocytochemistrywas performedwithC2fl/fl[Cre] ESC treated
with ethanol or 4HT at D0 and differentiated for 10 days. Western
blotting assays were performed using 20 mg of whole-cell lysates
prepared from the indicated mouse ESC as previously described
(Kranc et al., 2015).
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Chromatin Immunoprecipitation Assays
ChIP experiments and enrichment of target genomic elements by
qPCR were performed as previously described (Kranc et al., 2015)
using the primers listed in Table S1.
Production and Transduction of the Recombinant
8R-CITED2 Protein
Full-length human CITED2 cDNA and an oligonucleotide encod-
ing eight arginines (8R) were cloned into the pGEX6P1 vector
(GEHealthcare Life Sciences) to express a chimeric protein consist-
ing of the GST in fusion with the 8R domain and CITED2 (termed
GST-8R-CITED2, Figure S2). Newly constructed plasmids were vali-
dated by sequencing and the expression of fusion proteins tested
by western blot (Figure S2). Details of plasmid construction and
protein purification are available upon request.
Protein Interactions and Plasmids
For in vitrobinding assays,GST-CITED2 fusionproteins and in vitro
translated myc-ISL1 were prepared as previously described (Ma-
chado-Oliveira et al., 2015). Myc-ISL1 expression plasmid was con-
structed in pcDNA3 (Invitrogen) with an amino-terminal myc
epitope tag. Plasmids expressing flag-CITED2 and pPyCAGIP were
previously described (Chen et al., 2012). For BiFC assays, plasmids
expressing VEC-CITED2, VEN-p300CH1, VEC-GAL4, VEN-GAL4,
and the VEN vector were described elsewhere (Machado-Oliveira
et al., 2015). The plasmidVEN-ISL1 expressingVEN (aminoacid res-
idues 1–155 of the VENUS fluorescent protein) in fusion with ISL1
was obtained by subcloning ISL1 cDNA fragment of the Myc-ISL1
expression plasmid into the VEN vector in frame with the VEN
domain. All newly constructed plasmids were validated by
sequencing and the expression of fusion proteins tested by western
blot (Figure S3). Details of plasmid construction are available upon
request. For co-immunoprecipitation assays, 0.4 mg of whole-
cell extracts from HEK293T cells transfected with flag-CITED2
expressionvector alone or togetherwithmyc-ISL1vectorwereused.
Reporter Assays
Hep3B cells, a human hepatocellular carcinoma cell line with
low levels of endogenous CITED2, were plated in 24-well plates
at 2.5 3 104 cells per well and transfected the following day using
Lipofectamine 2000 (Invitrogen) with Mef2c-luc reporter (Witzel
et al., 2012) and expression vectors. CMV-lacZ plasmid was
co-transfected in all experiments, and both LUCIFERASE and
b-GALACTOSIDASE activities measured as previously described
(Kranc et al., 2015).
Statistical Analysis
Statistical significance was determined by two-tailed Student’s
t tests assuming unequal variance. p Values of <0.05 were consid-
ered statistically significant.
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